Operates in the controlled environment agriculture (CEA) sector through its subsidiary, Surna Cultivation Technologies. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 24% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 5.3× for every dollar of annual revenue.
No analyst target is on record for this company.
Executives buying with their own money is usually read as confidence in the company’s future.
Sales run at $2.8M a year. A small number, but proof the product has real buyers.
There is $9.5M in the vault; even if every debt were paid off, $9.2M would remain.
Over the last 12 months, company executives reported 13 buys and 6 sells. Management buying with its own money is usually read as a good sign.
A loss of $3.1M against $2.8M in annual sales. And on top of that, sales fell from the year before.
The price action doesn’t yet back an upward turn.
Costs swallow the gains that sales growth brings in.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown, the price history.